United States · FDA National Drug Code directory
Levetiracetam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0143-9673_15a7f063-f0e7-49dd-a520-f5708e5e8027
- Product NDC
- 0143-9673
- Form
- INJECTION
- Composition / generic term
- Levetiracetam
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20111013
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVETIRACETAM — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, GLASS in 1 BOX (0143-9673-10) / 5 mL in 1 VIAL, GLASS (0143-9673-01) · 0143-9673-10
- 25 VIAL, GLASS in 1 CARTON (0143-9673-25) / 5 mL in 1 VIAL, GLASS (0143-9673-01) · 0143-9673-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →